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Protocol
AbstrAct
Introduction Low vision and blindness adversely affect 
education and independence of children and young people. 
New ‘assistive’ technologies such as tablet computers 
can display text in enlarged font, read text out to the user, 
allow speech input and conversion into typed text, offer 
document and spreadsheet processing and give access to 
wide sources of information such as the internet. Research 
on these devices in low vision has been limited to case 
series.
Methods and analysis We will carry out a pilot 
randomised controlled trial (RCT) to assess the feasibility 
of a full RCT of assistive technologies for children/young 
people with low vision. We will recruit 40 students age 
10–18 years in India and the UK, whom we will randomise 
1:1 into two parallel groups. The active intervention will 
be Apple iPads; the control arm will be the local standard 
low-vision aid care. Primary outcomes will be acceptance/
usage, accessibility of the device and trial feasibility 
measures (time to recruit children, lost to follow-up). 
Exploratory outcomes will be validated measures of vision-
related quality of life for children/young people as well as 
validated measures of reading and educational outcomes. 
In addition, we will carry out semistructured interviews 
with the participants and their teachers.
Ethics and dissemination NRES reference 15/NS/0068; 
dissemination is planned via healthcare and education 
sector conferences and publications, as well as via patient 
support organisations.
Trial registration number NCT02798848; IRAS ID 
179658, UCL reference 15/0570. 
InTroducTIon
People are considered to have ‘low vision’ 
when their corrected visual acuity (VA) is 
poorer than 6/18 in their better eye, or their 
visual field is less than 10° from the point of 
fixation, but they use, or are potentially able 
to use, vision for the planning and/or execu-
tion of a task.1 There is an overlap with the 
definitions of visual impairment (VI) and 
severe VI/blindness. Low vision affects almost 
3 million children worldwide.2 3 It adversely 
affects educational and employment oppor-
tunities, causing economic hardship in adult 
life.4 5 Early assessment, provision of low-vi-
sion aids (LVAs) and training in their use 
are essential to improve functional vision 
(FV) and to allow children to fully participate 
in education and improve their quality of life 
(QoL).
In recent years, LVAs have been comple-
mented by ‘assistive technologies’ (AT). 
These include electronic vision enhance-
ment devices such as closed-circuit television 
(CCTV), computer screen reading soft-
ware, digital audio books, periodicals and 
text which can be accessed via computers, 
mobile phones and tablet computers. AT 
may enhance reading and writing skills, as 
well as communication with the world on 
an equal basis, thereby improving the QoL 
Strengths and limitations of this study
 ► Enrolment in different settings, pragmatically 
exploring feasibility.
 ► Low selection, performance and detection bias.
 ► Small sample size.
 ► Performance and social desirability bias (masking of 
participants not possible).
 ► Possible differential bias between study arms 
(attractiveness of active intervention).
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of people with low vision and facilitating the learning 
process.6
Teachers, parents and young people with low-vision 
report limited use of prescribed LVAs and other AT devices 
usually for fear of ‘standing out’. Electronic devices can 
have other limitations including a lack of portability, poor 
integration with school information technology networks 
and limitations of either input or output functions.
Tablet computers may help overcome many of these 
problems as they are portable and capable of running a 
wide range of software and of accessing wireless networks. 
More importantly, acceptability by young people may 
be high. Numerous applications are available, such as 
screen magnifiers, optical character recognition and 
text-to-speech conversion. All manufacturers provide 
‘accessibility features’. The Apple iPad, recommended 
by low-vision support charities such as the Royal National 
Institute for Blind People and the Royal London Society 
for the Blind, increases reading speed in adults with low 
vision7 and is used by many people with low vision.8
Tablet computers are of considerably lower cost 
(around £400–1600 per student) than current standard 
classroom technology, such as CCTV (which can cost up 
to £6400 with distance and near camera, per student). 
Tablet computers offer the additional advantages of 
direct access to school intranets, social acceptability and 
word document and spreadsheet processing. Addition-
ally, the price of tablet computers is likely to fall, whereas 
the price of CCTVs has remained high.
In the UK, support funding for children and young 
people with VI in local authority-maintained settings has 
traditionally been administered by their local authority. 
There is increasingly a shift of funding streams, for 
example, children with VI may attend educational 
settings which are not funded or maintained by the local 
authority, or individual funding may be agreed with the 
family (self-directed support). Robust information about 
the performance of different devices is vitally important 
for educational settings and families and carers.
We have carried out two systematic Cochrane reviews of 
the paediatric low-vision literature and have found that 
to date, no clinical trials of AT for young people with low 
vision have been conducted.9 10 Instead, the literature is 
limited to small non-randomised case series and cohort 
studies, mostly of optical devices. Informal discussions 
with young people with VI, their families and teachers 
indicate that those who have access to tablet computers 
such as Apple iPads find their accessibility features very 
useful, and would support research comparing this AT 
with conventional LVAs.
MeThods and analysIs
Our hypothesis is that tablet computer-based AT may 
have high acceptability and usage by children and 
young people with low vision, and may improve their FV, 
vision-related QoL (VRQoL) and access to education. As 
no preliminary data on trial feasibility are available, we 
will carry out a pilot study to assess whether or not a defin-
itive trial exploring this issue is feasible.
Primary objective
The principal research question is: ‘Is it feasible to 
recruit young people with low vision into a randomised 
controlled trial testing the effect of electronic assistive 
technologies on reading, educational and quality of life 
outcome measures?’
secondary research questions
1. Is the active intervention (tablet computer) acceptable 
to young people, their families/carers and their 
teachers?
2. Is the active intervention accessible, and do 
participants use it?
3. Estimate VRQoL measures, FV measures and reading 
and educational outcome measures by intervention 
group at 6 months
4. Have there been any adverse events (loss of motivation, 
negative peer comments) about using the AT?
5. What are the costs associated with the active 
intervention?
Trial design
This is a parallel 1:1 two-arm pilot randomised controlled 
trial (RCT); the experimental intervention will be an 
Apple iPad tablet computer with low-vision applications, 
and the control intervention will consist of the conven-
tional low-vision support as per standard clinical care, 
which includes optical LVA and/or CCTV.
study setting
There will be three recruitment sites, one in India (L 
V Prasad Eye Institute (LVPEI), Hyderabad, Telan-
gana; Meera and L B Deshpande Centre for Sight 
Enhancement, a tertiary eye care hospital) and two in 
the UK—The Child Development Centre in Bedford 
(a multidisciplinary community health, education and 
social care facility for children with developmental needs 
and disabilities) and the low-vision clinic for children 
and young people at Moorfields Eye Hospital (a tertiary 
eye care facility in London). The decision to have two 
very different settings reflects the study funders’ aim to 
provide people in low-income countries with equal access 
to innovation, and to shorten the timescale of implemen-
tation of novel approaches in low-income settings.
Inclusion criteria
We will include young people aged 10–18 years with low 
vision, defined as ‘best corrected visual acuity (BCVA) 
for distance between less than 6/18 (0.48 logMAR) and 
3/60 (1.30 logMAR) in the better eye’ (WHO), who are 
able to read printed material and who are not currently 
using, and have not previously used, tablet computer for 
educational purposes (figure 1). We will include students 
who have access to a tablet computer already but do not 
use it for educational purposes. We will include students 
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Figure 1 Flowchart showing planned participant flow (after Consort extension for pilot and feasibility studies19). CCTV, closed-
circuit television.
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who use a laptop. We will also include students who use 
or have previously used optical LVAs such as magnifiers, 
telescopes and CCTV systems.
exclusion criteria
Young people who are currently using or are prior 
users of a tablet computer for educational purposes (at 
school or frequently for homework) will be excluded. 
We accept that many videos and games children watch 
on tablet computers can be seen as educational, and that 
many children will use a tablet computer occasionally for 
research for homework. We will include young people 
using a tablet computer in this way.
Should participants in the control group receive a 
tablet computer from their local VI team or from their 
educational setting or if they start taking their own tablet 
computer to school, they will be removed from the trial 
and no further data collection will take place.
Near VA equivalent to 6/18 (0.48 logMAR) or better 
will not be an exclusion criterion, as even though students 
may perform well on a near acuity test, their reading 
acuity may be less than the near acuity measured in a 
clinical setting. Furthermore, as functional reading acuity 
can gradually reduce over the course of the day, there 
may be an increase in the need for optical magnification 
towards the end of the day, and when completing home-
work. Figure 1 summarises the design of the trial; each of 
the trial aspects is described in detail below.
Interventions
All participants recruited in the India and London site 
will receive a comprehensive low-vision assessment with 
an optometrist, including the prescription and supply of 
optimal refractive correction, tints and optical devices 
(magnifiers, telescopes), discussion and demonstration of 
electronic magnifiers, signposting to appropriate services 
and liaison with teachers for VI and class teachers.
The active intervention will be the use of a tablet computer 
(Apple iPad) for educational purposes at school and at 
home. The device will run word processing, spreadsheet 
and slide presentation files (Microsoft Office for iPad). 
These will allow students to import documents from the 
school’s learning environment onto their device, work on 
them and export them back to the teacher. Users will be 
given information and instruction on voice-over (text-to-
speech), magnification and contrast settings in the iOS 
software. In addition, we will install the video magnifier, 
colour identifying and image recognition application 
‘ViaOpta Daily’. The UK devices will have WiFi enabled 
to access school wireless networks. Additionally, those in 
India will have wireless data (3G) connectivity.
None of these applications is a medical device; they there-
fore do not require CE marking (confirmed by Medicines 
and Healthcare Products Regulatory Agency (MHRA)). 
We will activate the device accessibility features and install 
the applications before participants receive the devices. 
In London and India, study optometrists will train partic-
ipants in the use of devices, features and applications. In 
Bedford, the team for visually impaired pupils will support 
this training. We envisage an initial training session of 
2 hours in the first week, followed by telephone support 
or follow-up visits to the setting if required. For partic-
ipants recruited in London, each participant’s teacher 
for the vision impaired will be informed of their inclu-
sion in this study. Letters will be sent to the class teacher, 
teacher for the vision impaired and school special educa-
tion needs coordinator requesting that the young people 
be allowed to use their device in the classroom.
In India, participants were provided with training in 
the use of the devices and iPad at the low-vision reha-
bilitation centre. Additional support was provided over 
the phone to children who faced some difficulty with 
using the iPad initially.
The control intervention will consist of the comprehen-
sive low-vision assessment only. Due to differences in the 
recruitment route at Bedford, participants in the control 
group at Bedford will not be reassessed but will continue 
with their current spectacles and low-vision devices and 
will continue to be monitored by the VI team.
outcomes
Primary outcomes
The primary outcomes of this trial relate to feasibility of a 
full trial. There will be four primary outcomes: (1) recruit-
ment rate over 6 months, (2) retention of participants 
until 3 months after randomisation, (3) acceptance/
usage of the allocated device and (4) accessibility of the 
active intervention device.
Our recruitment target at both the site in India and the 
UK sites is 20 participants each over 6 months. We will 
consider that a definitive trial is feasible if we enrol 90% 
of this figure (n=18) during this period and/or if 100% 
are enrolled over 7 months. We will record the number of 
eligible young people declining to participate and their 
reasons for not wishing to take part. We will also capture 
whether any children dropped out of the study and why.
We will measure acceptance/usage of the allocated 
device using a participant diary; we will summarise usage 
for the electronic database as ordinal variable: 0=no 
acceptance, 1=used sometimes, 2=used frequently. We 
will define success as 80% of participants in the active 
intervention group using the device ‘frequently’.
Accessibility of the active intervention device will be 
determined by asking participants to play a touch-based 
game, ‘Piano Tiles’. In this game, the player has to touch 
moving black tiles that move down the screen. Following an 
introduction to the game using the ‘classic’ version, we will 
assess the young person’s score in the ‘zen’ version over 15 s 
and record the best score of three attempts. We will convert 
the game score to an ordinal variable for capture within the 
pilot database as follows: score 0–15: ordinal variable 0=low 
accessibility, 16–35: 1=medium accessibility, greater than 35: 
2=high accessibility. The protocol authors agreed on using 
this scoring system based on five children with good and 
with low vision playing this game; this system is at present 
not validated, and this pilot trial will allow us to collect data 
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about the range of scores achieved by the population of 
interest.
Exploratory/secondary outcomes
In addition to the primary outcomes, which will inform a 
future full RCT, we will collect data on a range of measures 
of visual function used in healthcare settings. Specifi-
cally, we will record functional visual ability, as measured 
by Cardiff Visual Ability Questionnaire for Children 
(CVAQC)11 for UK participants, and the L V Prasad Func-
tional Vision Questionnaire (LVP-FVQII) for participants 
in India.12 While it would be desirable to use the same 
instrument in both settings, differences in language and 
activities of daily living mean that there is no validated, 
universal tool that could be used both in India and in the 
UK.
Across all sites, we will measure VRQoL, using the Impact 
of Vision Impairment for Children Questionnaire.13
In the UK only, we will use three reading assessment 
tools which are available in English, but not Telugu, the 
local language spoken by most children in Hyderabad: 
(1) the Neale Analysis of Reading Ability (NARA, a test 
of reading accuracy, comprehension and speed),14 15 a 
tool which measures visual function and comprehension. 
This is a tool commonly used in educational settings; it 
has only been used in one previous study with children 
with low vision. (2) To measure reading speed, we will use 
the International Reading Speed Texts (IReST).16 (3) to 
measure peak reading speed, near VA and critical print 
size, we will use the MNREAD Acuity Charts, University 
of Minnesota, USA (MNREAD) test.17 NARA and IREST 
will be tested at baseline using the participant’s currently 
preferred LVA, and at 3 and 6 months using the allocated 
study device, excluding text-to-speech conversion; the 
assessment will be recorded as audio file for evaluation 
by a masked observer. MNREAD will be performed using 
spectacle correction only.
From the participant’s diary and from semistruc-
tured interviews (see online supplementary material), 
we will record as free text the participant’s experience 
of independent access to the curriculum, any adverse 
outcomes (loss of motivation, negative peer comments) 
and accessibility and impact of the allocated device on 
the participant. At the end of the observation period, 
we will collect feedback from the participants’ teachers 
with regards to their impression of the impact of the allo-
cated device on participants. We will report the cost of 
the devices as cost of device and training. We will provide 
initial training as part of the study. For ongoing technical 
support, we will rely on the manufacturers’ and suppliers’ 
support helplines.
Lastly, we will record demographic data (age at study 
entry, gender, ethnic group), ophthalmic history (time 
since diagnosis of VI, underlying ophthalmic diag-
nosis) and visual function (BCVA for distance and near, 
monocularly and binocularly, at each timepoint, recorded 
in logMAR; reading acuity on the MNREAD chart with 
refractive correction, but without LVA).18
Participant timeline
Each participant will be in the study for 6 months from 
randomisation, with assessments at baseline, 3 and 6 months. 
The schedule of assessments is summarised in figure 2.
sample size
This trial will enrol 40 students, 20 in the UK and 20 in 
India. A sample size of 20 is commonly used in feasibility 
studies. As this is the first RCT of an AT for children 
with low vision, a formal sample size calculation was not 
possible; there are no data on expected recruitment 
and retention. We decided on a target sample size that 
appears achievable over a 6-month period at one site in 
India and two sites in the UK. In addition, there are no 
data on effect size of AT for reading in children, and no 
data on effect size of conventional LVAs on any of the 
selected outcomes other than near and distance acuity. A 
sample size of 20 per site therefore appears appropriate 
to gather initial information.
recruitment
We will identify eligible participants from low-vision 
clinics at Moorfields in London, from students known to 
their local vision impairment teams in Bedford Borough 
and Central Bedfordshire and the low-vision clinic at the 
LVPEI in Hyderabad.
The initial approach about the study will be conducted 
as follows:
1. At MEH London: a member of the clinical team 
providing low-vision services for children and young 
people will tell the family about the study and gain 
permission to be approached by a member of the 
research team. Moorfields also operate an opt-out 
policy which allows research teams to approach 
patients eligible for research about research projects. 
This policy clearly states that patients/families are free 
to decline study participation. There is no coercion.
2. At CDC Bedford: Students known to the Bedfordshire 
teachers for visually impaired students will be 
approached, along with their family.
3. At LVPEI: a member of the clinical team will first 
approach patients and their family.
Once a young person and their family have expressed an 
interest in taking part, we will provide verbal and written 
study information. An accredited paediatric optometrist 
who is a member of the research team (MDC, VKG, RT, 
SB) will obtain written consent from a parent or carer, 
and will invite children/young people to give their assent 
in writing or verbally.
assignment of interventions
Allocation sequence generation and implementation
Young people who agree to take part will be randomised to 
receive either a tablet computer with low-vision applications 
or standard low-vision care. Allocation will be at a 1:1 ratio. 
At MEH London and CDC Bedford, randomisation will 
be prepared by the senior data manager in the Research 
& Development (R&D) department using permuted 
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blocks of varying sizes in the statistical programme STATA. 
Researchers will phone Moorfields R&D department after 
each enrolment to obtain the randomisation allocation; the 
senior data manger will record patient’s study ID, hospital 
number, randomisation allocation and randomisation date 
on the trial randomisation log file. Randomisation for the 
participants at the LVPEI, India, will use a web-based tool 
(https://www. sealedenvelope. com), operated by an optom-
etrist in the low-vision clinic team who is not involved in the 
study. The researcher will contact the optometrist to obtain 
information about the allocated treatment as participants 
are enrolled.
Allocation concealment mechanisms
The study optometrist will contact the senior data manager 
(Moorfields) or the member of staff holding the randomis-
ation schedule (LVP) for randomisation, so while allocation 
sequence is concealed from the research team, the allo-
cated intervention will not be concealed. As participants 
attend a wide range of schools, the risk of contamination by 
participants exchanging allocated equipment is low. Each 
participant will receive a password required to use their 
device and will be asked not to share it with others.
Masking
Masking of participants to the intervention will not be 
possible, which may cause performance bias. In order to 
avoid detection bias, we will mask outcome assessors to 
the intervention by recording reading performance as 
audio files (NARA, IREST), which will be subsequently 
evaluated by a masked observer. CVAQC and LVP-FVQII 
questionnaires will be administered by a masked observer. 
Diaries will be reviewed in masked fashion.
data collection, management and analysis
Data collection methods
Data will be collected from patients in accordance with 
the patient consent form, patient information sheet 
and the study protocol. Patients will be assigned a study 
number after consent prior to randomisation. This 
number will be used on all case report forms, question-
naires and interview materials. Two separate databases 
Figure 2 Schedule of enrolment, interventions and assessments (after SPIRIT20 21). CCTV, closed-circuit television; IVI-C, 
Impact of Vision Impairment for Children; LVA, low-vision aid; VRQoL, vision-related quality of life.
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will be built, one for UK and another for LVP which will 
capture pilot information for analysis. This will contain 
demographic data and information on the primary 
outcomes only.
Exploratory data will be captured as follows: all sites 
will use a standardised paper-based case report form 
and a standardised Microsoft Office Excel spreadsheet 
as database. At MEH London, MC will collect data and 
transfer them onto the spreadsheet; at CDC Bedford, RT 
and at LVP, SB and VKG will carry out data collection and 
transfer.
data management (handling, processing and storage)
Data within the MEH database will be analysed by AQ, 
who will not meet the participants or be involved in 
data collection. UCL as study sponsor will act as the data 
controller for the study. The data from LVP will remain 
with VKG for statistical analysis and she will act as the data 
controller.
For the data from MEH London and CDC Bedford, 
ADN will process, store and dispose of all described 
data in accordance with all applicable legal and regula-
tory requirements, including the Data Protection Act 
1998 and any amendments thereto. Data will be stored 
centrally and kept in locked, secure access filing cabinets 
or on password-protected NHS computers on hospital 
premises; this includes electronic data and case report 
forms, questionnaires and interview materials.
For the data from the LVPEI, India, VKG will process, 
store and dispose of all described data in accordance with 
all applicable legal and regulatory requirements. Data 
will be stored centrally at the LVPEI, Hyderabad, and 
kept in locked, secure access filing cabinets or on pass-
word-protected hospital computers on hospital premises; 
this includes electronic data and case report forms, ques-
tionnaires and interview materials.
UCL and each participating site recognise that there 
is an obligation to archive study-related documents at 
the end of the study. The chief investigator confirms that 
she will archive the study master file at Moorfields Eye 
Hospital for the period stipulated in the protocol and in 
line with all relevant legal and statutory requirements. 
The principal investigator at each participating site agrees 
to archive his/her respective site’s study documents for 
Moorfields Eye Hospital, the Child Development Centre 
Bedford and the LVPEI, and in line with all relevant legal 
and statutory requirements.
statistical methods
This is a pilot RCT, and data will be used to help design 
a definitive study. The dataset in India and the dataset in 
the UK will be handled and analysed separately, as rando-
misation methods and some of the outcomes measures 
(such as functional visual ability) differ between the two 
settings. We will use descriptive statistical methods only 
(proportions, mean/SD if data are normally distributed 
and median/IQR if not), and will not make comparisons 
between groups.
Participant retention
This is one of the primary outcomes mentioned earlier. 
Compliance, defined as usage of the allocated device, will 
be monitored by diary. We will attempt to reduce attri-
tion bias by staying in touch with participants throughout 
the study, by text messages, emails and phone calls and 
(in Bedford) visits to the educational setting. If partici-
pants wish to withdraw after they have been allocated to 
a treatment group, we will ask them to undergo a final 
assessment. We will record reasons for withdrawal on the 
case report form (free text). Data collected up to the 
point of withdrawal will be used in the data analysis.
data monitoring
The sponsor’s data monitoring and auditing procedures 
will apply, that is, each site will, twice a year, send the 
sponsor an update on the following information: delega-
tion log, adverse event log and deviation log. In addition, 
the lead site (Moorfields London) will send the sponsor 
a copy of the annual progress report when it is submitted 
to the Research Ethics Committee.
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